Heterogeneity in congenital melanocytic nevi contributes to multicentric melanomagenesis

Akiko Honobe; Kazuko Sakai; Yosuke Togashi; Takehiro Ohnuma; Tatsuyoshi Kawamura; Kazuto Nishio; Takashi Inozume

doi:10.1016/j.jdermsci.2020.09.004

Heterogeneity in congenital melanocytic nevi contributes to multicentric melanomagenesis

Akiko Honobe, Kazuko Sakai, Yosuke Togashi, Takehiro Ohnuma, Tatsuyoshi Kawamura, Kazuto Nishio, Takashi Inozume

研究成果 › 査読

本文言語	English
ページ（範囲）	217-219
ページ数	3
ジャーナル	Journal of dermatological science
巻	100
号	3
DOI	https://doi.org/10.1016/j.jdermsci.2020.09.004
出版ステータス	Published - 12月 2020
外部発表	はい

ASJC Scopus subject areas

生化学
分子生物学
皮膚病学

文献へのアクセス

10.1016/j.jdermsci.2020.09.004

他のファイルとリンク

引用スタイル

@article{909fa74cd15c4450b7adc854be0b731d,

title = "Heterogeneity in congenital melanocytic nevi contributes to multicentric melanomagenesis",

author = "Akiko Honobe and Kazuko Sakai and Yosuke Togashi and Takehiro Ohnuma and Tatsuyoshi Kawamura and Kazuto Nishio and Takashi Inozume",

note = "Funding Information: A.H., K.S., T.O., T.K., K.N. and T.I. have no conflict of interest to declare. Y.T. received honoraria from Bristol-Myers Squibb Co. Ltd., Ono Pharmaceutical Co. Ltd, AstraZeneca K.K., and MSD K.K., and received research funds from Ono Pharmaceutical Co. Ltd, AstraZeneca K.K., and KOTAI Biotechnologies Inc. outside this work. Funding Information: T.I. is supported by Grant-in-Aid for Scientific Research (C) 19K08744 from Ministry of education . ",

year = "2020",

month = dec,

doi = "10.1016/j.jdermsci.2020.09.004",

language = "English",

volume = "100",

pages = "217--219",

journal = "Journal of dermatological science",

issn = "0923-1811",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Heterogeneity in congenital melanocytic nevi contributes to multicentric melanomagenesis

AU - Honobe, Akiko

AU - Sakai, Kazuko

AU - Togashi, Yosuke

AU - Ohnuma, Takehiro

AU - Kawamura, Tatsuyoshi

AU - Nishio, Kazuto

AU - Inozume, Takashi

N1 - Funding Information: A.H., K.S., T.O., T.K., K.N. and T.I. have no conflict of interest to declare. Y.T. received honoraria from Bristol-Myers Squibb Co. Ltd., Ono Pharmaceutical Co. Ltd, AstraZeneca K.K., and MSD K.K., and received research funds from Ono Pharmaceutical Co. Ltd, AstraZeneca K.K., and KOTAI Biotechnologies Inc. outside this work. Funding Information: T.I. is supported by Grant-in-Aid for Scientific Research (C) 19K08744 from Ministry of education .

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85092621768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092621768&partnerID=8YFLogxK

U2 - 10.1016/j.jdermsci.2020.09.004

DO - 10.1016/j.jdermsci.2020.09.004

M3 - Letter

C2 - 33039242

AN - SCOPUS:85092621768

SN - 0923-1811

VL - 100

SP - 217

EP - 219

JO - Journal of dermatological science

JF - Journal of dermatological science

IS - 3

ER -